タンパク質アッセイの世界市場規模：エンドユーザー別、用途別、技術別、製品タイプ別、地域別、範囲および予測

タンパク質アッセイ市場の評価、2024年～2031年

プロテオミクスとゲノミクスの研究活動の活発化と、創薬と市場開拓の重視が、タンパク質アッセイ市場の大きな促進要因となっています。Verified Market Researchのアナリストによると、タンパク質アッセイ市場は、2023年に評価された約25億米ドルの収益を上回り、2031年までに52億5,000万米ドルの評価に達すると推定されます。

様々な疾患に対する新薬に対する世界の要望は、薬剤の研究開発努力を促進し、タンパク質の測定、活性分析、検証のためのタンパク質アッセイの使用を要求し、結果として市場成長を増加させています。このような新薬需要の急増により、市場は2024年から2031年にかけてCAGR9.7%で成長します。

タンパク質アッセイ市場定義/概要

タンパク質アッセイは、生物学的物質中のタンパク質の濃度、構造、機能を定量・分析する技術です。これらの検査は、生化学、分子生物学、医学研究を含む多くの科学分野で重要です。タンパク質アッセイは、医薬品開発、臨床診断、バイオマーカーの同定、タンパク質の精製など、幅広い用途があります。

さらに、創薬においては、標的タンパク質との相互作用を評価することにより、候補となる薬剤の有効性を評価するためにタンパク質アッセイが使用されます。臨床診断では、疾患の診断や治療効果の評価に役立つ特定のバイオマーカーを検出するため、タンパク質アッセイは重要です。

研究開発活動の増加は市場にどのような影響を与えるか？

バイオテクノロジーや製薬産業における研究開発（R&D）活動、特に医薬品の発見、開発、製造手順には著しい成長が見られます。タンパク質アッセイは、タンパク質の定量、薬剤の試験、医薬品の有効性と安全性の判定など、これらの研究開発業務で使用されています。研究開発費の増加は、革新的な治療法や個別化医療に対する需要の増加と相まって、タンパク質アッセイ市場の主な促進要因となっています。

より洗練された、高感度かつ迅速なタンパク質アッセイ法の開発は、タンパク質分析の効率を向上させる。比色法、蛍光法、発光法は、タンパク質含有量のより正確で信頼性の高い測定法を提供するために進化してきました。自動化と小型化は、タンパク質分析にかかる時間と費用を削減しながら、ハイスループットスクリーニングを可能にする技術的ブレークスルーの2つの例です。これらの技術的進歩は、様々なアプリケーションにおけるタンパク質アッセイの魅力と適用性を高め、市場の拡大を後押ししています。

ゲノミクス、プロテオミクス、個別化医療を含むライフサイエンス分野の世界の成長により、タンパク質アッセイの需要が増加しています。タンパク質を理解し分析することは、バイオマーカー探索、疾患研究、治療開発など、これらの領域における多くのアプリケーションに不可欠です。

さらに、慢性疾患の頻度の増加、新たな診断や治療法の必要性が、臨床研究や診断におけるタンパク質アッセイの需要を押し上げ、市場の拡大をもたらしています。

タンパク質アッセイ市場の成長を妨げる主な障害は？

タンパク質アッセイ市場では、異なる検査プラットフォームや検査方法間で標準化が行われていないことが大きな障害となっており、その結果、結果の再現性や比較可能性に問題が生じています。この不一致は、正確な測定が要求される研究や臨床の場面で特に顕著であり、採用の遅れの原因となっています。

タンパク質アッセイの開発および商業化、特に診断や治療用途には、米国食品医薬品局（FDA）や欧州医薬品庁（EMA）などの機関が課す厳しい規制基準が適用されます。このような規制当局への対応には時間と費用がかかり、特に新規参入企業や中小企業にとっては大きな負担となります。また、変化する規範や基準への継続的なコンプライアンスは、リソースとスキルの両面で障壁となり、市場拡大を制限します。

目次

第1章 世界のタンパク質アッセイ市場：イントロダクション

• 市場概要
• 調査範囲
• 前提条件

第2章 エグゼクティブサマリー

第3章 VERIFIED MARKET RESEARCHの調査手法

• データマイニング
• バリデーション
• 一次資料
• データソース一覧

第4章 タンパク質アッセイの世界市場展望

• 概要
• 市場力学
  • 促進要因
  • 抑制要因
  • 機会
• ポーターのファイブフォースモデル
• バリューチェーン分析
• 規制の枠組み

第5章 タンパク質アッセイの世界市場：タイプ別

• 概要
• 色素結合アッセイ
• 銅イオンベースアッセイ
• テストストリップベースアッセイ
• その他

第6章 タンパク質アッセイの世界市場：製品別

• 概要
• 試薬
• キット
• 装置およびアクセサリー

第7章 タンパク質アッセイの世界市場：技術別

• 概要
• 比色ベースのタンパク質アッセイ
• 蛍光ベースタンパク質アッセイ
• 吸光度ベースのタンパク質アッセイ

第8章 タンパク質アッセイの世界市場：用途別

• 概要
• 創薬と医薬品開発
• 疾病診断
• その他

第9章 タンパク質アッセイの世界市場：エンドユーザー別

• 概要
• 製薬・バイオテクノロジー企業
• 病院
• 臨床研究所
• 学術機関
• その他

第10章 タンパク質アッセイの世界市場：地域別

• 概要
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • その他欧州
• アジア太平洋
  • 中国
  • 日本
  • インド
  • その他アジア太平洋地域
• 世界のその他の地域
  • ラテンアメリカ
  • 中東・アフリカ

第11章 世界のタンパク質アッセイ市場の競合情勢

• 概要
• 各社の市場シェア
• ベンダー情勢
• 主な開発戦略

第12章 企業プロファイル

• Bio-Rad Laboratories
• Thermo Fisher Scientific
• Merck KGaA
• Danaher Corporation
• Cell Signaling Technology
• Abcam plc
• PerkinElmer Inc.
• QIAGEN
• Lonza
• Bio-Techne

第13章 付録

• 関連調査

Protein Assays Market Valuation - 2024-2031

Increased research activity in proteomics and genomics, as well as a greater emphasis on medication discovery and development, are significant drivers fueling the Protein Assays Market. According to the analyst from Verified Market Research, the Protein Assays Market is estimated to reach a valuation of USD 5.25 Billion by 2031, surpassing a revenue of aroundUSD 2.5 Billion valued in 2023.

The global desire for new medications for a wide range of diseases is driving drug research and development efforts, demanding the usage of protein assays for protein measurement, activity analysis, and validation, consequently increasing market growth. This surge in demand for new drugs enables the market to grow at aCAGR of 9.7% from 2024 to 2031.

Protein Assays Market: Definition/ Overview

Protein assays are techniques for quantifying and analyzing the concentration, structure, and function of proteins in a biological material. These tests are critical in many scientific areas, including biochemistry, molecular biology, and medical research. Protein assays have a wide range of applications, including drug development, clinical diagnostics, biomarker identification, and protein purification.

Furthermore, in drug discovery, protein assays are used to evaluate the efficacy of putative drug candidates by evaluating their interactions with target proteins. Protein assays are important in clinical diagnostics because they detect specific biomarkers that help diagnose diseases and evaluate therapy responses.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

How do the Increasing Research and Development Activities Influence the Market?

There is tremendous growth in research and development (R&D) activity in the biotechnology and pharmaceutical industries, particularly in medication discovery, development, and manufacturing procedures. Protein assays are used in these R&D operations to quantify proteins, test drugs, and determine the efficacy and safety of pharmaceutical goods. Increased R&D expenditure, combined with increased demand for innovative therapies and personalized medicine, is a primary driver of the Protein Assays Market.

The development of more sophisticated, sensitive, and faster protein assay methods improves the efficiency of protein analysis. Colorimetric, fluorometric, and luminescence assays have evolved to provide more accurate and reliable measures of protein content. Automation and miniaturization are two examples of technological breakthroughs that enable high-throughput screening while reducing the time and expense involved with protein analysis. These technical advancements increase the appeal and applicability of protein assays in a variety of applications, hence boosting market expansion.

The global growth of the life sciences sector, which includes genomics, proteomics, and personalized medicine, has increased demand for protein assays. Understanding and analyzing proteins is critical for many applications in these domains, including biomarker discovery, disease research, and treatment development.

Furthermore, the growing frequency of chronic diseases, as well as the need for new diagnoses and therapies, drive demand for protein assays in clinical research and diagnostics, resulting in market expansion.

Which are the Primary Obstacles Hindering the Growth of Protein Assays Market?

The absence of standardization across different test platforms and methods poses a significant difficulty in the Protein Assays Market, resulting in problems with reproducibility and comparability of results. This discrepancy is especially significant in research and clinical contexts, where precise measurements are required, and causing delayed adoption.

Protein assay development and commercialization, particularly for diagnostic or therapeutic uses, are subject to severe regulatory standards imposed by agencies such as the United States Food and Drug Administration (FDA) and the European Medicines Agency (EMA). Navigating these regulatory routes is time-consuming and expensive, particularly for newer and smaller businesses. Also, ongoing compliance with changing norms and standards presents a barrier in terms of both resources and skill, limiting market expansion.

Category-Wise Acumens

How do Ease of Use and Convenience Contribute to the Sales of Dye-binding Assays?

According to VMR analysis, the dye-binding assays segment is estimated to hold the largest market share in the type segment during the forecast period. Dye-binding assays provide a simple and rapid method for protein quantification that may be carried out in most laboratory settings without the use of costly equipment or highly specialized skills. They are a popular choice among researchers and technicians due to their simplicity and accessibility, especially for routine analysis and applications requiring high throughput.

Economic factors play an important influence in the use of certain tests in research and industrial applications. Dye-binding assays are often less expensive than other types of protein assays, making them an appealing alternative for labs with tight budgets or those who need to run a large number of assays regularly. The decreased cost per test enables broader application in a variety of settings, ranging from academic research to industrial quality control.

Furthermore, dye-binding assays and other leading segments are often compatible with a wide variety of samples, such as cell lysates, serum, and recombinant proteins. This versatility allows them to be used in a wide range of research domains and applications, from fundamental biological research to medication discovery and development. Furthermore, their capacity to adapt and integrate with current protocols and equipment adds to their widespread adoption and commercial dominance.

What factors drive the protein assays for Drug Discovery and Development?

The drug discovery and development segment is estimated to grow at the highest CAGR in the Protein Assays Market during the forecast period. The pharmaceutical and biotechnology businesses are increasing their investment in R&D activities. This is in reaction to the rising demand for new therapeutic medications to meet unmet medical requirements such as chronic diseases, cancer, and rare disorders. Protein assays play an important part in the drug development process, from initial screening to target selection and validation, making them must-have tools in R&D laboratories.

Furthermore, there is a growing emphasis on personalized medicine, which seeks to customize treatments to specific patient profiles such as genetic makeup and protein expression patterns. Protein assays are critical for discovering and quantifying biomarkers that might predict medication response or toxicity, hence facilitating the creation of more tailored and effective treatments. This personalized approach to drug development is primarily reliant on powerful protein analysis techniques, emphasizing the significance of the Protein Assays Market in drug discovery and development.

Country/Region-wise Acumens

How does a Strong Biotechnology Sector Influence the Market Dynamics of North America?

According to VMR analysts, North America is estimated to dominate the Protein Assays Market during the forecast period. North America is home to some of the world's largest and most important biotechnology and pharmaceutical businesses, which make significant investments in research and development (R&D). This strong R&D environment is bolstered by significant investment in innovation, resulting in high demand for protein assays in drug discovery, development procedures, and disease research. The existence of these industrial titans, together with a thriving ecosystem of smaller biotech firms and start-ups, fuels the demand for protein assays to support their substantial research operations.

Furthermore, the region has a sophisticated research infrastructure, including world-class universities, research institutions, and clinical research organizations (CROs). These organizations frequently interact with the biotech and pharmaceutical industries on research projects, increasing demand for protein assays.

Will High Healthcare Expenditure in China and India Prove Fruitful for the Asia Pacific Market?

Asia Pacific region is estimated to be the most opportunistic region for the Protein Assays Market during the forecast period. Countries in the Asia Pacific, such as China, India, South Korea, and Singapore, are experiencing significant economic growth, which has resulted in increasing healthcare spending and investment in life sciences research. Governments and private sector players are making major investments in healthcare infrastructure, research centers, and biotechnology parks, creating a favorable environment for the Protein Assays Market to grow. This funding aims to improve healthcare outcomes and promote innovation in drug research and diagnostics, where protein assays play an important role.

Furthermore, academic and clinical research are becoming increasingly important in the Asia Pacific area, with countries aspiring to become hubs of innovation and scientific discovery. This includes major investments in higher education and research institutions, as well as efforts to develop relationships among academics, government, and industry. The emphasis on research areas such as cancer, infectious diseases, and genetics, where protein analysis is critical, is resulting in an expanded use of protein assays.

Competitive Landscape

The competitive landscape of the Protein Assays Market is defined by a dynamic and innovative environment in which entities compete for prominence through technological breakthroughs, product portfolio expansion, and penetration into emerging markets.

Some of the prominent players operating in the Protein Assays Market include:

Thermo Fisher Scientific, Bio-Rad Laboratories, Merck KGaA, Danaher Corporation, Cell Signaling Technology, Abcam plc, PerkinElmer Inc., QIAGEN, Lonza, Bio-Techne, BioVision Inc, Geno Technology Inc.

Latest Developments

In October 2023, Thermo Fisher Scientific introduced their new "QuantiFluor ONE Protein Assay". This assay is intended to provide high sensitivity and a large dynamic range for protein measurement in a variety of biological samples.

In September 2023, Merck KGaA collaborated with "AIVITA Animal Health" to develop and commercialize a novel blood test for the early diagnosis of canine parvovirus. This test utilizes protein assay technology for a faster and more accurate diagnosis.

In August 2023, Bio-Rad Laboratories announced its new "Chemiluminescent Western Blot Detection Kits". These kits provide enhanced sensitivity and lower background noise for Western blot analysis, a crucial protein test technique.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL PROTEIN ASSAYS MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL PROTEIN ASSAYS MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis
• 4.5 Regulatory Framework

5 GLOBAL PROTEIN ASSAYS MARKET, BY TYPE

• 5.1 Overview
• 5.2 Dye-binding Assays
• 5.3 Copper-ion-based Assays
• 5.4 Test Strip-based Assays
• 5.5 Others

6 GLOBAL PROTEIN ASSAYS MARKET, BY PRODUCT

• 6.1 Overview
• 6.2 Reagents
• 6.3 Kits
• 6.4 Instruments & Accessories

7 GLOBAL PROTEIN ASSAYS MARKET, BY TECHNOLOGY

• 7.1 Overview
• 7.2 Colorimetric-based Protein Assays
• 7.3 Fluorescence-based Protein Assays
• 7.4 Absorbance-based Protein Assays

8 GLOBAL PROTEIN ASSAYS MARKET, BY APPLICATION

• 8.1 Overview
• 8.2 Drug Discovery and Development
• 8.3 Disease Diagnosis
• 8.4 Others

9 GLOBAL PROTEIN ASSAYS MARKET, BY END-USER

• 9.1 Overview
• 9.2 Pharmaceutical & Biotechnology Companies
• 9.3 Hospitals
• 9.4 Clinical Laboratories
• 9.5 Academic Institutes
• 9.6 Others

10 GLOBAL PROTEIN ASSAYS MARKET, BY GEOGRAPHY

• 10.1 Overview
• 10.2 North America
  • 10.2.1 U.S.
  • 10.2.2 Canada
  • 10.2.3 Mexico
• 10.3 Europe
  • 10.3.1 Germany
  • 10.3.2 U.K.
  • 10.3.3 France
  • 10.3.4 Rest of Europe
• 10.4 Asia Pacific
  • 10.4.1 China
  • 10.4.2 Japan
  • 10.4.3 India
  • 10.4.4 Rest of Asia Pacific
• 10.5 Rest of the World
  • 10.5.1 Latin America
  • 10.5.2 Middle East & Africa

11 GLOBAL PROTEIN ASSAYS MARKET COMPETITIVE LANDSCAPE

• 11.1 Overview
• 11.2 Company Market Share
• 11.3 Vendor Landscape
• 11.4 Key Development Strategies

12 COMPANY PROFILES

• 12.1 Bio-Rad Laboratories
  • 12.1.1 Overview
  • 12.1.2 Financial Performance
  • 12.1.3 Product Outlook
  • 12.1.4 Key Developments
• 12.2 Thermo Fisher Scientific
  • 12.2.1 Overview
  • 12.2.2 Financial Performance
  • 12.2.3 Product Outlook
  • 12.2.4 Key Developments
• 12.3 Merck KGaA
  • 12.3.1 Overview
  • 12.3.2 Financial Performance
  • 12.3.3 Product Outlook
  • 12.3.4 Key Developments
• 12.4 Danaher Corporation
  • 12.4.1 Overview
  • 12.4.2 Financial Performance
  • 12.4.3 Product Outlook
  • 12.4.4 Key Developments
• 12.5 Cell Signaling Technology
  • 12.5.1 Overview
  • 12.5.2 Financial Performance
  • 12.5.3 Product Outlook
  • 12.5.4 Key Developments
• 12.6 Abcam plc
  • 12.6.1 Overview
  • 12.6.2 Financial Performance
  • 12.6.3 Product Outlook
  • 12.6.4 Key Developments
• 12.7 PerkinElmer Inc.
  • 12.7.1 Overview
  • 12.7.2 Financial Performance
  • 12.7.3 Product Outlook
  • 12.7.4 Key Developments
• 12.8 QIAGEN
  • 12.8.1 Overview
  • 12.8.2 Financial Performance
  • 12.8.3 Product Outlook
  • 12.8.4 Key Developments
• 12.9 Lonza
  • 12.9.1 Overview
  • 12.9.2 Financial Performance
  • 12.9.3 Product Outlook
  • 12.9.4 Key Developments
• 12.10 Bio-Techne
  • 12.10.1 Overview
  • 12.10.2 Financial Performance
  • 12.10.3 Product Outlook
  • 12.10.4 Key Developments

13 Appendix

• 13.1 Related Research